Article Text

Download PDFPDF
Extended report
Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression
  1. Daniel Aletaha1,
  2. Farideh Alasti1,
  3. Josef S Smolen1,2
  1. 1Division of Rheumatology, Department of Medicine 3, Medical University Vienna, Vienna, Austria
  2. 2Second Department of Medicine, Hietzing Hospital, Vienna, Austria
  1. Correspondence to Daniel Aletaha, Department of Medicine 3, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria; daniel.aletaha{at}


Background Disease activity in rheumatoid arthritis (RA) can be measured clinically (eg, swollen joint count (SJC)) or systemically (eg, C reactive protein (CRP)). In general, both contribute to the progression of joint damage, but the relevance of residual inflammation in patients near remission is unclear.

Objective To determine the independent contribution of SJC and CRP to progression of joint damage in patients near remission.

Methods Data from methotrexate monotherapy arms of the ASPIRE, ERA, Leflunomide, PREMIER and TEMPO trials (n=1184) were pooled and the average SJC and CRP values from visits at 6, 9 and 12 months were determined. The two variables were then dichotomised into active and inactive, where inactive was defined as a mean. Radiographic outcomes were assessed according to these definitions.

Results The greatest progression was seen in patients in whom both SJC and CRP were active and the smallest in those in whom both were inactive. If SJC was inactive, radiographic progression was not different between those with inactive or active CRP (0.7±4.3/year and 0.8±5.4/year, respectively, p=0.19). However, if CRP was inactive (<1 mg/dl), SJC status still determined radiographic progression (0.7±4.3/year and 1.8±5.6/year, for inactive and active SJC, respectively, p=0.004). The importance of SJC in patients with inactive CRP was also shown in a linear model (p=0.019), while CRP was not significantly different in patients with inactive SJC (p=0.40).

Conclusion In patients with RA who are near remission, the amount of joint swelling appears to be more predictive of radiographic progression than the amount of CRP.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding This study was supported through Coordination Theme 1 (Health) of the European Community's FP7; Grant Agreement number HEALTH-F2-2008–223404 (Masterswitch). This is a publication of the Joint and Bone Center for Diagnosis, Research and Therapy of Musculoskeletal Disorders of the Medical University of Vienna.

  • Competing interests DA: expert advice or speaker for Abbott, BMS, MSD, UCB, Pfizer, Roche. FA: none. JSS: grant/research support from Abbott, BMS, MSD, Pfizer, Roche; expert advice or symposia presentations for Abbott, Amgen, BMS, MSD, Pfizer, Roche, Sanofi-Aventis, UCB.

  • Provenance and peer review Not commissioned; externally peer reviewed.